Patients with multiple sclerosis (MS) treated with the drug rituximab had a significantly lower risk of relapse compared with MS patients receiving standard treatment. This has been shown in a phase 3 clinical trial by researchers ...
Jul 13, 2022
0
64
For healthy adults, the bivalent prefusion F respiratory syncytial virus (RSVpreF) vaccine is effective against symptomatic RSV infection and viral shedding, according to a study published in the June 23 issue of the New ...
Jun 23, 2022
0
17
For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, vaccine efficacy (VE) against symptomatic COVID-19 appears to peak at 120 days after the first dose, ...
Jun 13, 2022
0
19
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its COVID-19 vaccine among very young children were accurate, ahead of a decision next week on whether to authorize two ...
Jun 10, 2022
0
8
A new study by a University of Arkansas information systems researcher and his colleague at the University of Waikato in New Zealand shows that COVID vaccine trials conducted in geographic locations with low infection rates ...
May 24, 2022
0
105
Coronavirus-like particles (CoVLP), which are produced in plants, combined with an adjuvant (Adjuvant System 03 [AS03]) forms a candidate vaccine that is effective for preventing COVID-19, according to a study published online ...
May 5, 2022
0
63
Despite soaring cases and record-high COVID-19 hospitalizations, the United States is approaching the "threshold" of transitioning to living with the coronavirus as a manageable disease, Anthony Fauci said Tuesday.
Jan 11, 2022
0
19
Indonesian authorities on Monday granted emergency authorization for the use of five different COVID-19 vaccines as booster shots that will prioritize vulnerable groups.
Jan 10, 2022
0
3
A target trial emulation study found that in an elderly population of U.S. veterans with high comorbidity burden, mRNA vaccine efficacy at preventing infection with COVID-19 was substantially lower than previously reported ...
Dec 21, 2021
0
5
As the world faces an impending wave of COVID cases due to omicron, scientists are racing to assess vaccine efficacy against the new variant. In a new study, Rockefeller scientists report on their comprehensive analysis of ...
Dec 17, 2021
0
7
